JNJ
Income statement / Annual
Last year (2024), Johnson & Johnson's total revenue was $88.82 B,
an increase of 4.30% from the previous year.
In 2024, Johnson & Johnson's net income was $14.07 B.
See Johnson & Johnson,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/29/2024 |
12/31/2023 |
01/01/2023 |
01/02/2022 |
01/03/2021 |
12/29/2019 |
12/30/2018 |
12/31/2017 |
01/01/2017 |
01/03/2016 |
| Operating Revenue |
$88.82 B |
$85.16 B |
$79.99 B |
$78.74 B |
$82.58 B |
$82.06 B |
$81.58 B |
$76.45 B |
$71.89 B |
$70.07 B |
| Cost of Revenue |
$27.47 B
|
$26.55 B
|
$24.60 B
|
$23.40 B
|
$28.43 B
|
$27.56 B
|
$27.09 B
|
$25.44 B
|
$21.79 B
|
$21.54 B
|
| Gross Profit |
$61.35 B
|
$58.61 B
|
$55.39 B
|
$55.34 B
|
$54.16 B
|
$54.50 B
|
$54.49 B
|
$51.01 B
|
$50.10 B
|
$48.54 B
|
| Gross Profit Ratio |
0.69
|
0.69
|
0.69
|
0.7
|
0.66
|
0.66
|
0.67
|
0.67
|
0.7
|
0.69
|
| Research and Development Expenses |
$17.23 B
|
$15.09 B
|
$14.14 B
|
$14.28 B
|
$12.34 B
|
$11.36 B
|
$10.78 B
|
$10.59 B
|
$9.14 B
|
$9.05 B
|
| General & Administrative Expenses |
$21.97 B
|
$20.11 B
|
$20.25 B
|
$20.12 B
|
$22.08 B
|
$22.18 B
|
$22.54 B
|
$21.52 B
|
$20.07 B
|
$21.20 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$21.97 B
|
$20.11 B
|
$20.25 B
|
$20.12 B
|
$22.08 B
|
$22.18 B
|
$22.54 B
|
$21.52 B
|
$20.07 B
|
$21.20 B
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$39.20 B
|
$35.20 B
|
$34.38 B
|
$34.40 B
|
$34.42 B
|
$33.53 B
|
$33.32 B
|
$32.11 B
|
$29.21 B
|
$30.25 B
|
| Cost And Expenses |
$66.67 B
|
$61.75 B
|
$58.98 B
|
$57.80 B
|
$62.85 B
|
$61.09 B
|
$60.41 B
|
$57.55 B
|
$51.00 B
|
$51.79 B
|
| Interest Income |
$1.33 B
|
$1.26 B
|
$490.00 M
|
$53.00 M
|
$111.00 M
|
$357.00 M
|
$611.00 M
|
$385.00 M
|
$368.00 M
|
$128.00 M
|
| Interest Expense |
$755.00 M
|
$772.00 M
|
$276.00 M
|
$183.00 M
|
$201.00 M
|
$318.00 M
|
$1.01 B
|
$934.00 M
|
$726.00 M
|
$552.00 M
|
| Depreciation & Amortization |
$7.34 B
|
$7.49 B
|
$6.97 B
|
$7.39 B
|
$7.23 B
|
$7.01 B
|
$6.93 B
|
$5.64 B
|
$3.75 B
|
$3.75 B
|
| EBITDA |
$24.78 B |
$23.32 B |
$26.61 B |
$26.75 B |
$23.93 B |
$24.66 B |
$25.93 B |
$24.25 B |
$24.28 B |
$23.49 B |
| EBITDA Ratio |
0.28
|
0.27
|
0.33
|
0.34
|
0.29
|
0.3
|
0.32
|
0.32
|
0.34
|
0.34
|
| Operating Income Ratio |
0.25
|
0.27
|
0.26
|
0.27
|
0.24
|
0.26
|
0.26
|
0.25
|
0.29
|
0.26
|
| Total Other Income/Expenses Net |
-$5.46 B
|
-$8.35 B
|
-$1.65 B
|
-$1.77 B
|
-$3.24 B
|
-$3.64 B
|
-$3.18 B
|
-$1.22 B
|
-$1.09 B
|
$907.00 M
|
| Income Before Tax |
$16.69 B
|
$15.06 B
|
$19.36 B
|
$19.18 B
|
$16.50 B
|
$17.33 B
|
$18.00 B
|
$17.67 B
|
$19.80 B
|
$19.20 B
|
| Income Before Tax Ratio |
0.19
|
0.18
|
0.24
|
0.24
|
0.2
|
0.21
|
0.22
|
0.23
|
0.28
|
0.27
|
| Income Tax Expense |
$2.62 B
|
$1.74 B
|
$2.99 B
|
$1.38 B
|
$1.78 B
|
$2.21 B
|
$2.70 B
|
$16.37 B
|
$3.26 B
|
$3.79 B
|
| Net Income |
$14.07 B
|
$35.15 B
|
$17.94 B
|
$20.88 B
|
$14.71 B
|
$15.12 B
|
$15.30 B
|
$1.30 B
|
$16.54 B
|
$15.41 B
|
| Net Income Ratio |
0.16
|
0.41
|
0.22
|
0.27
|
0.18
|
0.18
|
0.19
|
0.02
|
0.23
|
0.22
|
| EPS |
5.84 |
13.88 |
6.83 |
7.93 |
5.59 |
5.74 |
5.75 |
0.48 |
6.08 |
5.57 |
| EPS Diluted |
5.79 |
13.72 |
6.73 |
7.81 |
5.51 |
5.63 |
5.61 |
0.47 |
5.93 |
5.48 |
| Weighted Average Shares Out |
$2.41 B
|
$2.53 B
|
$2.61 B
|
$2.63 B
|
$2.63 B
|
$2.63 B
|
$2.66 B
|
$2.68 B
|
$2.71 B
|
$2.76 B
|
| Weighted Average Shares Out Diluted |
$2.43 B
|
$2.56 B
|
$2.66 B
|
$2.67 B
|
$2.67 B
|
$2.68 B
|
$2.73 B
|
$2.75 B
|
$2.79 B
|
$2.81 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
